SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001028348-15-000002
Filing Date
2015-01-30
Accepted
2015-01-30 12:17:56
Documents
1
Group Members
BROOKSIDE CAPITAL PARTNERS FUND III, L.P.BROOKSIDE CAPITAL TRADING FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 BROOKSIDE 13D/A PTC THERAPEUTICS INC AS OF 1/30/15 PTCSchedule13DA4.txt SC 13D/A 13027
  Complete submission text file 0001028348-15-000002.txt   14757
Mailing Address JOHN HANCOCK TOWER 200 CLARENDON STREET BOSTON MA 02116
Business Address JOHN HANCOCK TOWER 200 CLARENDON STREET BOSTON MA 02116 617-516-2000
BROOKSIDE CAPITAL PARTNERS FUND LP (Filed by) CIK: 0001028348 (see all company filings)

IRS No.: 043313066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Subject) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87511 | Film No.: 15561840
SIC: 2834 Pharmaceutical Preparations